IP Library Granted Patent US 12661507
Granted Patent B2
US 12661507 · App. 17/716,431 · Granted Jun 23, 2026

Methods of treating neurodegenerative disorders with alternating electric fields

Inventors: Tali Voloshin-Sela (Haifa, IL); Lilach Avigdor (Haifa, IL); Eyal Dor-On (Haifa, IL); Moshe Giladi (Haifa, IL); Hila Fishman (Haifa, IL)
Assignee: Novocure GmbH
A61N1/36025A61N1/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12661507
App. No.
17/716,431
Granted
Jun 23, 2026
Kind
B2
Abstract

Methods of treating a neurodegenerative disorder in a subject are provided by applying alternating electric fields to the brain of the subject, optionally also administering a drug for treatment of the neurodegenerative disorder (e.g., Alzheimer's disease, Parkinson's disease, dementia) to the subject. In some instances, the neurodegenerative disorder can be treated by applying alternating electric fields to a brain of the human subject wherein the brain is tumor-free.

Claims (8)

1 . A method of treating a neurodegenerative disorder in a subject consisting essentially of applying alternating electric fields to a brain of the subject to reduce activity of GSK3β, wherein the alternating electric fields have an intensity of 1 V/cm to 20 V/cm (RMS) and a frequency between 50 kHz and 1 MHz, and wherein the neurodegenerative disorder is Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), dementia, or Parkinson's disease.

2 . The method of claim 1 , wherein the applying step has a duration of at least 24 hours.

3 . The method of claim 1 , wherein the applying step has a duration of at least 72 hours.

4 . The method of claim 1 , wherein the applying step has a duration of at least 30 days.

5 . The method of claim 1 , wherein the intensity is 1.0 V/cm to 2.5 V/cm (RMS).

6 . The method of claim 1 , wherein the brain is tumor-free.

7 . The method of claim 1 , further comprising diagnosing the subject with a neurodegenerative disorder.

8 . The method of claim 1 , wherein the subject is not diagnosed as having a tumor prior to applying the alternating electric fields.